Mednet Logo
HomeRadiation OncologyQuestion

How do you approach treatment of a subtotally resected low grade glioma in a young patient?

5
5 Answers
Mednet Member
Mednet Member
Radiation Oncology · Florida International University

The management philosophy for LGG is radically shifting. For years, the belief was that these were essentially "incurable", slow-growing tumors, and hence the original debate centered around observation versus resection; the observation camp is now squarely in the minority. The debate then shifted t...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Washington University School of Medicine

Given RTOG9802 showed OS benefit for RT/chemotherapy vs RT alone, which also included those with age <40 and STR, I would favor adjuvant RT AND chemotherapy (Buckner et al, NEJM 2016). Furthermore, there is this new diagnostic criteria based on CIMPACT-NOW consensus that low grade IDH-wildtype astro...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Yale Cancer Center At Smilow Cancer Hospital

Excellent discussion below. Given that the early vs. delayed XRT shows improvement in seizure-free survival, I think that earlier XRT is particularly beneficial for patients with seizures or large unresected or partially lesions that are already symptomatic. In my experience these large lesions are ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Colorado School of Medicine

In a young patient with a subtotally resected low grade glioma, I give the options of radiation therapy now vs at the time of symptomatic or imaging progression. In general, I favour delayed radiation therapy given the results of the European study that showed no change in survival outcomes. At the ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Missouri at Columbia, Ellis Fischel Cancer Cener

As stated above 9802 RT+PCV demonstrated survival advantage over RT alone which took years to see the OS benefit, implying a durable benefit to upfront treatment. So any high risk feature low grade glioma should be considered for adjuvant RT.

In terms of molecular factors, several excellent articles...

Register or Sign In to see full answer